NSEInvestor Presentation4d ago · 31 Jul 2026, 06:50 pm
Investor Presentation
Yasho Industries Limited · YASHO
✦ AI SummaryResults
Yasho Industries Limited has informed the Exchange about Investor Presentation for Q1FY27, which has been uploaded on the Company's website.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Yasho Industries Limited has informed the Exchange about Investor Presentation
Attachments (1)
📄pdf
Download →
8291904474_31072026184640_Investor_Presentation_Q1FY27.pdf
View document text
Date: July 31, 2026
To, To,
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block,
Dalal Street, Fort, Bandra-Kurla Complex, Bandra (East),
Mumbai – 400 001. Mumbai – 400 051.
Scrip Code: 541167 Symbol: YASHO
Dear Sir/ Madam,
Sub: Investor Presentation- Q1FY27
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, a copy of the Investor’s Presentation for Q1FY27 is
enclosed herewith, and the said Investor’s Presentation has also been uploaded on the Company’s
website at www.yashoindustries.com
We request you to kindly take the same on record.
Thanking You,
For Yasho Industries Limited
Rupali Verma
(Company Secretary & Compliance Officer)
Membership No. A42923
Encl: As above
YASHO INDUSTRIES LIMITED
REGISTERED OFFICE: Office No. 101/102, Peninsula Heights, C.D Barfiwala Marg, Juhu lane, Andheri (West), Mumbai – 400058, India
TEL: +91 22 62510100; FAX: +91 22 62510199; E-Mail: info@yashoindustries.com; CIN No: L74110MH1985PLC037900
INVESTOR PRESENTATION
Q1 FY2027
Safe Harbor
This presentation and the accompanying slides (the “Presentation”), which have been prepared by Yasho Industries Limited (the “Company”), have
been prepared solely for information purposesand do not constitute any offer, recommendationor invitation to purchaseor subscribe for any securities,
andshallnotformthe basisorbereliedoninconnectionwithanycontractorbindingcommitmentwhatsoever.Noofferingofsecuritiesofthe Company
willbemadeexceptbymeansofastatutoryofferingdocumentcontaining detailedinformationabouttheCompany.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no
representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and
reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may
considermaterial.Anyliabilityinrespectofthecontentsof,oranyomissionfrom,thisPresentationisexpresslyexcluded.
Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are
individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to
known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the
performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide,
competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological
implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market
risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from
results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this
Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and
theCompanyisnotresponsibleforsuchthirdpartystatementsandprojections.
COMPANY OVERVIEW
About Us
2 140+
Leading Specialty Chemicals Company
Business Categories Total Products
Incorporated in 1985 by Jhaveri Family and started its manufacturing
operations in 1993, Yasho Industries Limited (YIL) is a specialty chemicals
manufacturer engaged in producing high-performance ingredients used 1 50+
across industrial and consumer applications, including lubricant additives
and rubber chemicals
R & D Facility In-House Researchers
The company combines expertise in complex chemistry with a strong focus
on product innovation and process efficiency, enabling it to develop a
diversified portfolio of value-added products. 830+
Employees
Global Subsidiary
With integrated manufacturing capabilities and continuous investment in
R&D, Yasho is steadily moving up the value chain while catering to leading
global multinational corporations (MNCs), positioning itself as a scalable and
innovation-driven player in the specialty chemicals space.
50+ 40+
Global footprint across
Years of Excellence
Countries
Board of Directors
Mr. Vinod Jhaveri Mr. Parag Jhaveri Mr. YayeshJhaveri
Chairman & Executive Director Managing Director & CEO Whole Time Director
Mr. Anurag Surana Mr. U R Bhat Dr. Prakash Bhate Mrs. Sudha Navandar
Non-Executive Independent Director Non-Executive Independent Director Non-Executive Independent Director Non-Executive Independent Director
Diversified product Portfolio ready to capture growing demand
Consumer Division Industrial Division
Applications
Applications
• Flavours and fragrances; personal care products -cosmetics &
• Tyres, Automobile components, Conveyor belts, surgical gloves, latex
toiletries
gloves, condoms, balloons
• Agrochemicals & Pharmaceutical products
• Hydraulic, turbine, engine & gear oils, metal working fluids & greases
• Oral care preparations
• Stabilisers for acrylics, printing inks/coating, UPR resins and fibre
• Edible oil, Confectioneries & food stuff, Animal feed, Vitamin premix,
composite resins
Nutraceutical
Manufacturing plants (1/2)
About Pakhajan Plant
Pakhajan Plant
Spread across 42 acres, the plant features scalable infrastructure capabilities along
with an Inhouse Research Facility.
Business Rationale
Dedicated Plant for working on products which have potential growth in future.
Our Edge
Present Land utilization is 25% of the land parcel available.
Capable of supporting 20-25% growth without additional capex in infrastructure
Capex Incurred till date
The company incurred capex of ₹18.05 crore on this plant during the current year.
Peak Revenue Capacity
At optimal utilization, the existing site has the potential to generate peak revenue of
₹800–850 crore.
Manufacturing plants (2/2)
About Vapi Plant
Vapi Facilities
The plant comprises versatile manufacturing unit.
Business Rationale
Multi-functional plant-to create as many different chemistries as required.
Our Edge
Strategically located near key ports, enabling us to efficiently cater to global
customers while maintaining high standards of quality and timely delivery.
Peak Revenue Capacity
At optimal utilization, the site has the potential to generate peak revenue of₹650-700
crores.
Research & Development
R&D facilities
Number of Inhouse Researchers
The company has a strong in-house R&D team comprising more than 50 researchers
Area
The company operates a dedicated facility spread across 25,000+ sq. ft.
Location
The company’s in-house R&D facility is located at Pakhajan.
BUSINESS UPDATE
Management Commentary & Outlook
• Business Performance
The company maintained its strong growth momentum in Q1 FY27, reporting consolidated revenue of ₹ 307.74 croreand EBITDA of ₹ 74.42 crore,
supported by 42% year-on-year volume growth in Q1FY27. This was driven by an additional off-take by existing customers and acquisition of
marquee international customers. The company also forayed into Asian and African geographies. This is despite global supply challenges and the
middle-east crisis. The increase in margins was achieved by improved product mix, cost efficiencies and operating leverages.
The company is also expanding into industrial chemicals, focusing on products with opportunities arising from global demand.
• Financial Strength
The company’s debt-to-EBITDA ratio improved to1.86x inQ1 FY27, from 3.75x in Q4 FY26. The company remains committed to strengthening its
balance sheet.
Bank Loan Ratings of the Company
[Showing first 8,000 characters — download PDF for full document]